Results 141 to 150 of about 121,700,018 (217)

Model-Based Anticancer Effect of Botulinum Neurotoxin Type A1 on Syngeneic Melanoma Mice. [PDF]

Front Pharmacol, 2021
Kang WH, Ryu HJ, Kwak S, Yun HY.
europepmc   +1 more source

Effects of botulinum neurotoxin on spatio-temporal gait parameters of patients with chronic stroke: a prospective open-label study

, 2015
Nowadays, administration of botulinum neurotoxin type A is considered a safe, well tolerated and effective treatment for muscles tone reduction in focal spasticity care.
Gastaldi, Laura, Lisco, Giulia, Dimanico, U, Pastorelli, Stefano Paolo, Dimanico, U.   +4 more
core  

A translational preclinical strategy for chronic spinal cord injury: neuroprotective and regenerative potential of botulinum neurotoxin type A combined with muscle atrophy prevention via electrostimulation. [PDF]

Mil Med Res
Mastrorilli V, Luvisetto S, Ruggieri V, Raparelli G, Madaro L, Paggi LA, Parisi C, De Santa F, De Angelis F, D'Elia A, Massari R, Amadio S, Rossetto O, Vacca V, Caruso M, Sferrazza G, Pavone F, Marinelli S.   +17 more
europepmc   +1 more source

Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A. [PDF]

Natl J Maxillofac Surg, 2021
Chowdhury R, Roy D, Roy A.
europepmc   +1 more source

Presynaptic Terminal Proteins and Nicotinic Receptors Are Depleted from Mouse Parasympathetic Ganglionic Junctions Paralysed with Botulinum Neurotoxin Type A. [PDF]

Toxins (Basel)
Al-Sabi A, Lawrence GW.
europepmc   +1 more source

The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study. [PDF]

Toxins (Basel), 2022
Battaglia M, Borg MB, Torgano L, Loro A, Cosenza L, Bertoni M, Picelli A, Santamato A, Invernizzi M, Uberti F, Molinari C, Carda S, Baricich A.   +12 more
europepmc   +1 more source

Cell-Penetrating Botulinum Neurotoxin Type A Proteins Alleviate Skeletal Muscle Hypertrophy with Associated Alterations of Mitochondrial Homeostasis. [PDF]

Toxins (Basel)
Li L, Wei X, Jiang L, Gao Z, Liu J.
europepmc   +1 more source

Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope. [PDF]

Antibodies (Basel), 2022
Mechaly A, Diamant E, Alcalay R, Ben David A, Dor E, Torgeman A, Barnea A, Girshengorn M, Levin L, Epstein E, Tennenhouse A, Fleishman SJ, Zichel R, Mazor O.   +13 more
europepmc   +1 more source

Nodule Formation Associated With Botulinum Neurotoxin Type A Injections: Potential Triggers in 23 Patients. [PDF]

Plast Reconstr Surg Glob Open
Hassan L, Kroumpouzos G.
europepmc   +1 more source

Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia. [PDF]

J Neurol, 2021
Comella C, Ferreira JJ, Pain E, Azoulai M, Om S.   +4 more
europepmc   +1 more source